Holen Sie sich die Stockscreener-App
9.385
0.05%
0.005
Handel nachbörslich:
9.39
0.005
+0.05%
Schlusskurs vom Vortag:
$9.38
Offen:
$9.36
24-Stunden-Volumen:
29,395
Relative Volume:
1.18
Marktkapitalisierung:
$84.90M
Einnahmen:
$29.93M
Nettoeinkommen (Verlust:
$-545.30K
KGV:
-155.90
EPS:
-0.0602
Netto-Cashflow:
$3.38M
1W Leistung:
-2.95%
1M Leistung:
+5.21%
6M Leistung:
+54.11%
1J Leistung:
+48.36%
1-Tages-Spanne:
$9.25
$9.57
1-Wochen-Bereich:
$9.25
$9.88
52-Wochen-Spanne:
$4.52
$10.75
Immucell Corp Stock (ICCC) Company Profile
Firmenname
Immucell Corp
Sektor
Branche
Telefon
(207) 878-2770
Adresse
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
9.385 | 86.22M | 29.93M | -545.30K | 3.38M | -0.0602 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immucell Corp Aktie (ICCC) Neueste Nachrichten
[8-K] IMMUCELL CORP /DE/ Reports Material Event - Stock Titan
Jonathan Ocampo joins ImmuCell Commercial Team - Feedstuffs
ICCC Technical Analysis | Trend, Signals & Chart Patterns | IMMUCELL CORP (NASDAQ:ICCC) - ChartMill
ImmuCell Corp. Hits New 52-Week High of $10.65, Up 145% - MarketsMojo
ImmuCell Corporation (ICCC) Surges 3.75% to $10.50 as Bulls Test Key ResistanceNews Sentiment - The Legal Advocate
ImmuCell Shares Rose Ahead of Holiday; Tuesday’s Open in Focus - Bez Kabli
ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand - Yahoo Finance
ICCC SEC FilingsImmucell 10-K, 10-Q, 8-K Forms - Stock Titan
ImmuCell Corporation (ICCC) Climbs +10.76% — Resistance at $10.37 in Focus 2026-05-18Median Line - newsline.com
ImmuCell Corporation (NASDAQ:ICCC) Q1 2026 Earnings Call Transcript - Insider Monkey
ImmuCell Q1 Earnings Call Highlights - sharewise.com
Earnings call transcript: ImmuCell Q1 2026 marks milestone with revenue surge - Investing.com
ImmuCell (NASDAQ: ICCC) posts strong Q1 2026 growth, higher margins and cash - Stock Titan
ImmuCell (NASDAQ: ICCC) grows Q1 2026 revenue 28% and boosts earnings - Stock Titan
Calf-health maker ImmuCell secures $2M to expand First Defense output - Stock Titan
ImmuCell Corporation 2025 10-K/A Annual Report Filing Details, Address, and SEC Cover Information - Minichart
ImmuCell (NASDAQ: ICCC) files 10-K amendment to update exhibit list - Stock Titan
Here’s Why ImmuCell Corporation (ICCC) is Emerging as an Intriguing Micro-Cap Opportunity - Yahoo Finance
TradingKey - TradingKey
ImmuCell | 4: Statement of changes in beneficial ownership of securities-Director Basse Gloria F - Moomoo
ImmuCell Corporation Files Form 8-K with SEC: Company Details, NASDAQ Listing, and Key Entity Information - Minichart
ImmuCell keeps Q1 sales outlook unchanged ahead of May 15 results call - Stock Titan
Short Interest in ImmuCell Corporation (NASDAQ:ICCC) Decreases By 20.8% - MarketBeat
ImmuCell (NASDAQ:ICCC) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
The Christmas party is still ongoing in these stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - MSN
ImmuCell (NASDAQ: ICCC) outlines 2026 strategy, equity plan and pay - Stock Titan
ImmuCell (ICCC) director discloses 17,899 stock options grant details - Stock Titan
ImmuCell (NASDAQ: ICCC) director lists 17,899 stock options - Stock Titan
ImmuCell : Corporate Presentation (Investor Relations April 2026 Final) - marketscreener.com
The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell - Zacks Investment Research
ICCC (ImmuCell Corporation) rises 1.78 percent after posting a 0.31 dollar per share loss for Q4 2025.Elite Trading Signals - newser.com
ICCC ImmuCell Corporation shares gain nearly two percent following release of its Q4 2025 earnings report. - newsline.com
[Form 4] IMMUCELL CORP /DE/ Insider Trading Activity - Stock Titan
ImmuCell (ICCC) grants director 11,933 stock options at $7.60 - Stock Titan
Director Gloria Basse granted 11,933 ImmuCell (ICCC) stock options - Stock Titan
ImmuCell (ICCC) director Paul Wainman receives 11,933 stock options at $7.60 - Stock Titan
650K-share equity plan and officer exculpation up for vote — ImmuCell (NASDAQ: ICCC) - Stock Titan
ImmuCell (ICCC) VP Brockmann granted 5,000 incentive stock options - Stock Titan
ImmuCell (ICCC) director receives grant of 10,000 stock options - Stock Titan
ImmuCell (ICCC) director awarded 10,000 stock options at $5.49 strike - Stock Titan
ImmuCell (ICCC) director awarded 10,000 options at $5.49 exercise price - Stock Titan
ImmuCell (ICCC) director Steven Rosgen granted 10,000 stock options at $5.49 - Stock Titan
ImmuCell (ICCC) director receives 10,000 non-qualified stock options at $5.49 - Stock Titan
ImmuCell (ICCC) adds industry veterans to a smaller, more independent board - Stock Titan
ImmuCell appoints two directors, expands to 7-member board - Investing.com
Finanzdaten der Immucell Corp-Aktie (ICCC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immucell Corp-Aktie (ICCC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| te Boekhorst Paul Francis Oliv | President and CEO |
Dec 03 '25 |
Buy |
5.02 |
6,077 |
30,536 |
9,785 |
| te Boekhorst Paul Francis Oliv | President and CEO |
Dec 02 '25 |
Buy |
4.87 |
3,708 |
18,053 |
3,708 |
| Tomsche David Scott | Director |
Nov 25 '25 |
Buy |
4.76 |
1,633 |
7,781 |
4,740 |
| Tomsche David Scott | Director |
Nov 25 '25 |
Buy |
4.76 |
1,633 |
7,773 |
52,720 |
2.60%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):